California Life Sciences appoints Brent Fisk as Senior Vice President of Government Relations and External Affairs
July 10, 2023 12:57 ET
|
California Life Sciences
Washington, D.C., July 10, 2023 (GLOBE NEWSWIRE) -- California Life Sciences (CLS), the trade association representing California’s life sciences sector, announces Brent Fisk as Senior Vice...
Viracta Announces Scientific Advisory Board Formation
September 25, 2018 08:00 ET
|
Viracta Therapeutics, Inc.
SAN DIEGO, Sept. 25, 2018 (GLOBE NEWSWIRE) -- Viracta Therapeutics, Inc., a clinical-stage drug development company advancing innovative approaches to treat viral-associated cancers and other...
NantKwest and Viracta Therapeutics Announce Series B Financing and Immunotherapy Partnership
April 04, 2017 08:00 ET
|
Viracta Therapeutics, Inc.
CULVER CITY, Calif. and SAN DIEGO, April 04, 2017 (GLOBE NEWSWIRE) -- NantKwest, Inc. (Nasdaq:NK) and Viracta Therapeutics, Inc. announced the initial closing of a Series B Preferred financing round...
Viracta acquires Phase 2 epigenetic drug candidate from Chroma Therapeutics
November 30, 2016 08:00 ET
|
Viracta Therapeutics, Inc.
SAN DIEGO and LONDON, Nov. 30, 2016 (GLOBE NEWSWIRE) -- Viracta Therapeutics, Inc. announced completion of its acquisition of drug development candidate, VRx-3996, from Chroma Therapeutics, Ltd. ...